跳至主要内容
临床试验/NCT06346405
NCT06346405招募中不适用

Central Serous Chorioretinopathy and Micropulse Laser Treatment: Evaluation of Morphological and Functional Recovery

Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2023年5月31日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
36
试验地点
1
主要终点
Vessel density changes

研究概览

简要总结

To evaluate choroidal and choriocapillaris changes in patients with central serous chorioretinopathy, undergone sub threshold micropulse laser treatment, following any improvement with conservative therapy with Acetazolamide and/or Eplerenone

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of central serous chorioretinopathy (CSC) with no response to conservative therapy, consisted in Acetazolamide and Eplerenone after six months.
  • Foveal serous retinal detachment for at least 6 months.
  • Minimum age of 18 years old at the screening time
  • Reading and comprehension skills of informed consent

排除标准

  • Previous retinal treatment for CSC, except for Acetazolamide and Eplerenone
  • No diffuse retinal epitheliopathy
  • Other concomitant ocular diseases, such as age related macular degeneration, diabetic retinopathy, choroidal neovascularization
  • Not controlled glaucoma with eyedrops, or advanced glaucoma
  • Myopia or hypermetropia greater than 6 diopters
  • Opacities of dioptric media
  • Low quality of optical coherence tomography (OCT) and OCT-Angiography scans
  • Low quality images of Fluorescein angiography and indocyanine green angiography
  • No written consensus signed.

结局指标

主要结局

Vessel density changes

时间窗: 12 and 24 months

Evaluation of changes in vessel density of choriocapillaris by optical coherence tomography (OCT) angiography before and after treatment

次要结局

  • Choroidal thickness(12 and 24 months)
  • Quality of life (QoL)(12 and 24 months)
  • Metamorphopsia(12 and 24 months)
  • Choroidal thickness and vessel density(12 and 24 months)
  • Improvement in retinal function(12 and 24 months)
  • Qualitative analysis of retino-choroidal vascularization with identification of vascular pattern(12 and 24 months)
  • Ellipsoid zone and BCVA(12 and 24 months)
  • Metamorphopsia and BCVA(12 and 24 months)
  • Ellipsoid Zone Integrity(12 and 24 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Savastano Maria Cristina

Principal Investigator

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

研究点 (1)

Loading locations...

相似试验